Search
Menu
Home
HTB
2020
January
January 2020
Contents
Editorial
HTB 29 January 2020 online
Supplements
i-Base guide to HIV testing and sexual transmission (January 2020)
Antiretrovirals
FDA decision on long-acting cabotegravir/rilpivirine (Cabenuva, Vocabria) injections delayed due to scale-up manufacturing problems
Fostemsavir submitted to EMA for treating multidrug resistant HIV
Gilead announces licensing agreement for Rockefeller University bNAbs
PK and drug interactions
Updates to Liverpool University drug interactions website
Guidelines
US HIV Guidelines updated (December 2019)
BHIVA 2019 audit shows early access to ART but U=U and peer support both need to be improved
Vaccines and microbicides
FluAGE study supports BHIVA recommendations for HIV positive people to have annual flu shot
PDFs
29 January 2020 vol 21 no 1
HTB RSS
Early access
IAS public letter: Why HIV could be poised for a monumental comeback
6 February 2025
Lenacapavir for PrEP submitted to EMA for EU and global use
4 February 2025
New mpox vaccination sites open in the UK
3 February 2025
Impact of US elections and executive orders on global health: waiver covers PEPFAR with restrictions
1 February 2025
All early access reports
Current issues
February 2025
January 2025
December 2024
Back issues
Special report
Impact of US elections and executive orders on global health: waiver covers PEPFAR with restrictions
1 February 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate